Article    Table of Contents                    Full Text of this article    PDF of this article (PDFs free after 6 months)    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Westermann, J.    Hoffmann, J. C.    Related Articles in PubMed    PubMed Citation    PubMed

REVIEW

Migration of T Cells in Vivo: Molecular Mechanisms and Clinical Implications

Jürgen Westermann, MD; Britta Engelhardt, MD; and Jörg C. Hoffmann, MD

21 August 2001 | Volume 135 Issue 4 | Pages 279-295

T cells play an important role in the pathogenesis of chronic and autoimmune inflammatory diseases. They are found in high numbers in involved tissues, such as the lamina propria of the gut in patients with Crohn disease. Modifying T-cell number and function may therefore be of therapeutic value.

In principle, two mechanisms may be responsible for the development of such T-cell infiltrates: 1) an increased rate of T-cell immigration into involved tissues or 2) an increased proliferation rate, decreased T-cell death (apoptosis) rate, and prolonged retention of T cells already in the tissue. Based on the theory that T cells selectively target affected tissues through organ-specific adhesion-molecule pathways, current anti-adhesion-molecule therapy aims to interfere selectively with T-cell entry to stop tissue damage.

However, the traffic of labeled T cells in unmanipulated animals shows that the entry of T-cell subsets into tissues is not organ-specific, even under conditions of differing adhesion molecule and chemokine receptor expression. In contrast, within various tissues, both movement and survival of T-cell subsets differ considerably. These observations suggest that the differential expression of adhesion molecules and chemokine receptors on T cells serves at least two functions in vivo. First, during migration of T cells out of the bloodstream, the different adhesion-molecule pathways provide redundancy, which guarantees that T-cell subsets are able to enter the different tissues in sufficient numbers (security). Second, adhesion molecules and chemokine receptors mediate T-cell interactions within the tissue that are characteristic for each subset and each microenvironment and determine the nature of the ensuing immune response (selectivity). Shifting the focus of anti-adhesion-molecule therapy toward the T cells in diseased tissue may lead to new treatment options.

Author and Article Information

From Medizinische Universitat zu Lübeck, Lübeck; Max-Planck Institut für physiologische und klinische Forschung, W.G. Kerckhoff-Institut, Bad Nauheim; and Medizinische Klinik, Universitä tskliniken des Saarlandes, Homburg/Saar, Germany.

Acknowledgments: The authors thank colleagues in the department of functional and applied anatomy for their continuous support, especially K. Bankes, I. Dressendörfer, S. Lopez-Kostka, and F. Weidner. They also thank A. Gebert, B. Lüttig, R. Pabst, R. Schwinzer, and T. Tschernig (Medical School of Hannover, Germany) for critical comments on the manuscript; M. Peter for help in preparing the figures; and S. Fryk for help with the English language.

Grant Support: By the Deutsche Forschungsgemeinschaft (SFB 244 A7 and We 1175/4-3).

Requests for Single Reprints: Jürgen Westermann, MD, Institute of Anatomy, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany; e-mail, westermann{at}anat.mu-luebeck.de.

Current Author Addresses: Dr. Westermann: Institute of Anatomy, University of Lübeck, Ratzeburger Allee 160, 23538 Lü beck, Germany.

Dr. Engelhardt: Abteilung für Vaskuläre Zellbiologie, Max-Planck-Institut, Parkstrasse 1, D-61231 Bad Nauheim, Germany.

Dr. Hoffmann: Innere Medizin II, Universitätskliniken des Saarlandes, D-66421 Homburg, Germany.

This article has been cited by other articles:

				L. D. Spargo, L. G Cleland, M. P Cockshell, and G. Mayrhofer Recruitment and proliferation of CD4+ T cells in synovium following adoptive transfer of adjuvant-induced arthritis Int. Immunol., June 1, 2006; 18(6): 897 - 910. [Abstract] [Full Text] [PDF]

				G. P.A. Rice, H.-P. Hartung, and P. A. Calabresi Anti-{alpha}4 integrin therapy for multiple sclerosis: Mechanisms and rationale Neurology, April 26, 2005; 64(8): 1336 - 1342. [Abstract] [Full Text] [PDF]

				J. Westermann, U. Bode, A. Sahle, U. Speck, N. Karin, E. B. Bell, K. Kalies, and A. Gebert Naive, Effector, and Memory T Lymphocytes Efficiently Scan Dendritic Cells In Vivo: Contact Frequency in T Cell Zones of Secondary Lymphoid Organs Does Not Depend on LFA-1 Expression and Facilitates Survival of Effector T Cells J. Immunol., March 1, 2005; 174(5): 2517 - 2524. [Abstract] [Full Text] [PDF]

				S. R. Thurau, T. R. Mempel, A. Flugel, M. Diedrichs-Mohring, F. Krombach, N. Kawakami, and G. Wildner The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACS Int. Immunol., November 1, 2004; 16(11): 1573 - 1582. [Abstract] [Full Text] [PDF]

				J. R. Conejo-Garcia, F. Benencia, M. C. Courreges, P. A. Gimotty, E. Khang, R. J. Buckanovich, K. A. Frauwirth, L. Zhang, D. Katsaros, C. B. Thompson, et al. Ovarian Carcinoma Expresses the NKG2D Ligand Letal and Promotes the Survival and Expansion of CD28- Antitumor T Cells Cancer Res., March 15, 2004; 64(6): 2175 - 2182. [Abstract] [Full Text] [PDF]

				O. Boyman, H. P. Hefti, C. Conrad, B. J. Nickoloff, M. Suter, and F. O. Nestle Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-{alpha} J. Exp. Med., March 1, 2004; 199(5): 731 - 736. [Abstract] [Full Text] [PDF]

				A. Schwarz, E. Tutsch, B. Ludwig, E. C. Schwarz, A. Stallmach, and M. Hoth Ca2+ Signaling in Identified T-lymphocytes from Human Intestinal Mucosa: RELATION TO HYPOREACTIVITY, PROLIFERATION, AND INFLAMMATORY BOWEL DISEASE J. Biol. Chem., February 13, 2004; 279(7): 5641 - 5647. [Abstract] [Full Text] [PDF]

				M R Kok, B J Baum, P P Tak, and S R Pillemer Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjogren's syndrome Ann Rheum Dis, November 1, 2003; 62(11): 1038 - 1046. [Abstract] [Full Text] [PDF]

				S. R. Lewin, R. M. Ribeiro, G. R. Kaufmann, D. Smith, J. Zaunders, M. Law, A. Solomon, P. U. Cameron, D. Cooper, and A. S. Perelson Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection J. Immunol., October 15, 2002; 169(8): 4657 - 4666. [Abstract] [Full Text] [PDF]

				J. B. Smith and M. K. Haynes Rheumatoid Arthritis--A Molecular Understanding Ann Intern Med, June 18, 2002; 136(12): 908 - 922. [Abstract] [Full Text] [PDF]